| Financial Year |
March 31 2023 |
| Monetary Funds |
1,168,240,324.63 |
| Held-for-trading Financial Assets |
70,970,000.00 |
| Notes Receivable |
225,980,000.00 |
| Accounts Receivable |
1,716,401,909.65 |
| Advances to Suppliers |
499,708,838.17 |
| Other Receivables |
14,955,998.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
960,602,386.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
398,567,073.54 |
| Total Current Assets |
5,343,795,436.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
21,874,608.10 |
| Fixed Assetes |
731,851,059.89 |
| Under-construction Projects |
195,494,715.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
191,025,731.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,685,221.25 |
| Deferred Income Tax Assets |
29,327,934.94 |
| Other Non-Current Assets |
26,540,798.61 |
| Sub-Total of Non-Current Assets |
1,265,662,771.12 |
| Total Assets |
6,609,458,208.09 |
| Short-Term Loans |
2,054,990,300.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
522,818,295.53 |
| Accounts Payable |
217,459,052.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,297,465.96 |
| Taxes Payable |
45,048,203.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,129,357.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
16,598,056.81 |
| Sub-Total of Current Liabilities |
2,900,965,895.19 |
| Long-term Loans |
235,000,000.00 |
| Bonds Payable |
712,082,837.41 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,491,505.74 |
| Other Non-Current Liabilities |
8,081.42 |
| Sub-Total of Non-Current Liabilities |
1,037,803,192.11 |
| Total Liabilities |
3,938,769,087.30 |
| Paid-In Capital(Or Share Stock) |
439,000,916.00 |
| Capital Surplus |
614,218,844.40 |
| Surplus Reserve |
89,981,266.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,280,534,568.45 |
| Minority Stockholder's Interest |
107,125,752.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,563,563,368.13 |
| Owner's Equity（Stockholder's Equity） |
2,670,689,120.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,609,458,208.09 |
